Danaher Gross Margin 2012-2026 | DHR
Current and historical gross margin for Danaher (DHR) over the last 10 years. The current gross profit margin for Danaher as of June 30, 2026 is %.
| Danaher Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $25.11B | $14.69B | 58.51% |
| 2026-03-31 | $24.78B | $14.60B | 58.94% |
| 2025-12-31 | $24.57B | $14.52B | 59.11% |
| 2025-09-30 | $24.27B | $14.45B | 59.53% |
| 2025-06-30 | $24.01B | $14.33B | 59.66% |
| 2025-03-31 | $23.82B | $14.23B | 59.74% |
| 2024-12-31 | $23.88B | $14.21B | 59.50% |
| 2024-09-30 | $23.74B | $14.10B | 59.37% |
| 2024-06-30 | $23.57B | $13.97B | 59.27% |
| 2024-03-31 | $23.74B | $13.86B | 58.39% |
| 2023-12-31 | $23.89B | $14.03B | 58.74% |
| 2023-09-30 | $21.03B | $12.43B | 59.13% |
| 2023-06-30 | $23.07B | $13.74B | 59.58% |
| 2023-03-31 | $24.90B | $15.15B | 60.81% |
| 2022-12-31 | $26.64B | $16.19B | 60.76% |
| 2022-09-30 | $26.60B | $16.24B | 61.05% |
| 2022-06-30 | $26.17B | $16.02B | 61.21% |
| 2022-03-31 | $25.63B | $15.69B | 61.22% |
| 2021-12-31 | $24.80B | $15.24B | 61.44% |
| 2021-09-30 | $28.07B | $16.96B | 60.44% |
| 2021-06-30 | $26.72B | $15.83B | 59.24% |
| 2021-03-31 | $24.80B | $14.29B | 57.60% |
| 2020-12-31 | $22.28B | $12.48B | 55.98% |
| 2020-09-30 | $20.39B | $11.23B | 55.05% |
| 2020-06-30 | $18.89B | $10.44B | 55.28% |
| 2020-03-31 | $18.03B | $10.07B | 55.85% |
| 2019-12-31 | $17.91B | $9.98B | 55.74% |
| 2019-09-30 | $15.56B | $8.63B | 55.48% |
| 2019-06-30 | $16.04B | $8.88B | 55.39% |
| 2019-03-31 | $16.57B | $9.22B | 55.61% |
| 2018-12-31 | $17.05B | $9.51B | 55.76% |
| 2018-09-30 | $16.80B | $9.37B | 55.76% |
| 2018-06-30 | $16.48B | $9.22B | 55.93% |
| 2018-03-31 | $16.01B | $8.88B | 55.48% |
| 2017-12-31 | $15.52B | $8.57B | 55.23% |
| 2017-09-30 | $17.83B | $9.85B | 55.27% |
| 2017-06-30 | $17.43B | $9.60B | 55.08% |
| 2017-03-31 | $17.16B | $9.50B | 55.35% |
| 2016-12-31 | $16.88B | $9.33B | 55.29% |
| 2016-09-30 | $13.57B | $7.60B | 56.02% |
| 2016-06-30 | $12.95B | $7.21B | 55.67% |
| 2016-03-31 | $13.66B | $7.47B | 54.67% |
| 2015-12-31 | $14.43B | $7.77B | 53.83% |
| 2015-09-30 | $18.58B | $9.81B | 52.78% |
| 2015-06-30 | $19.78B | $10.37B | 52.42% |
| 2015-03-31 | $19.78B | $10.34B | 52.29% |
| 2014-12-31 | $19.75B | $10.33B | 52.30% |
| 2014-09-30 | $19.60B | $10.24B | 52.23% |
| 2014-06-30 | $19.56B | $10.21B | 52.19% |
| 2014-03-31 | $19.34B | $10.09B | 52.16% |
| 2013-12-31 | $19.12B | $9.96B | 52.09% |
| 2013-09-30 | $18.83B | $9.79B | 52.01% |
| 2013-06-30 | $18.57B | $9.65B | 51.93% |
| 2013-03-31 | $18.39B | $9.51B | 51.69% |
| 2012-12-31 | $18.26B | $9.42B | 51.56% |
| 2012-09-30 | $18.00B | $9.20B | 51.09% |
| 2012-06-30 | $18.03B | $9.10B | 50.47% |
| 2012-03-31 | $17.12B | $8.66B | 50.62% |
| 2011-12-31 | $16.09B | $8.18B | 50.82% |
| 2011-09-30 | $14.61B | $7.57B | 51.81% |
| 2011-06-30 | $13.25B | $7.00B | 52.80% |
| 2011-03-31 | $12.83B | $6.69B | 52.09% |
| 2010-12-31 | $12.55B | $6.41B | 51.04% |
| 2010-09-30 | $11.78B | $5.92B | 50.20% |
| 2010-06-30 | $11.44B | $5.62B | 49.16% |
| 2010-03-31 | $10.90B | $5.28B | 48.45% |
| 2009-12-31 | $10.52B | $5.07B | 48.20% |
| 2009-09-30 | $11.23B | $5.29B | 47.14% |
| 2009-06-30 | $11.69B | $5.48B | 46.92% |
| 2009-03-31 | $12.30B | $5.78B | 47.02% |
| 2008-12-31 | $12.70B | $5.94B | 46.79% |
| 2008-09-30 | $12.66B | $5.94B | 46.91% |
| 2008-06-30 | $12.19B | $5.68B | 46.60% |
| 2008-03-31 | $11.53B | $5.32B | 46.12% |
| 2007-12-31 | $11.03B | $5.04B | 45.72% |
| 2007-09-30 | $10.45B | $4.75B | 45.45% |
| 2007-06-30 | $10.13B | $4.59B | 45.32% |
| 2007-03-31 | $9.84B | $4.42B | 44.90% |
| 2006-12-31 | $9.47B | $4.20B | 44.34% |
| 2006-09-30 | $9.05B | $3.97B | 43.85% |
| 2006-06-30 | $8.61B | $3.73B | 43.31% |
| 2006-03-31 | $8.19B | $3.55B | 43.31% |
| 2005-12-31 | $7.87B | $3.41B | 43.25% |
| 2005-09-30 | $7.70B | $3.31B | 42.97% |
| 2005-06-30 | $7.48B | $3.20B | 42.79% |
| 2005-03-31 | $7.17B | $3.04B | 42.35% |
| 2004-12-31 | $6.89B | $2.89B | 41.99% |
| 2004-09-30 | $6.40B | $2.66B | 41.59% |
| 2004-06-30 | $5.96B | $2.46B | 41.33% |
| 2004-03-31 | $5.64B | $2.30B | 40.83% |
| 2003-12-31 | $5.29B | $2.14B | 40.41% |
| 2003-09-30 | $5.08B | $2.04B | 40.19% |
| 2003-06-30 | $4.92B | $1.96B | 39.78% |
| 2003-03-31 | $4.77B | $1.88B | 39.36% |
| 2002-12-31 | $4.58B | $1.79B | 39.02% |
| 2002-09-30 | $4.22B | $1.62B | 38.33% |
| 2002-06-30 | $3.97B | $1.51B | 38.08% |
| 2002-03-31 | $3.78B | $1.44B | 38.15% |
| 2001-12-31 | $3.78B | $1.44B | 38.17% |
| 2001-09-30 | $3.90B | $1.50B | 38.55% |
| 2001-06-30 | $3.98B | $1.54B | 38.56% |
| 2001-03-31 | $3.92B | $1.51B | 38.57% |
| 2000-12-31 | $3.78B | $1.46B | 38.72% |
| 2000-09-30 | $3.59B | $1.36B | 37.95% |
| 2000-06-30 | $3.39B | $1.29B | 38.01% |
| 2000-03-31 | $3.24B | $1.22B | 37.69% |
| 1999-12-31 | $3.13B | $1.17B | 37.29% |
| 1999-09-30 | $3.08B | $1.07B | 34.56% |
| 1999-06-30 | $3.03B | $1.04B | 34.31% |
| 1999-03-31 | $3.02B | $1.08B | 35.84% |
| 1998-12-31 | $2.91B | $1.09B | 37.42% |
| 1998-09-30 | $2.78B | $1.19B | 42.67% |
| 1998-06-30 | $2.68B | $1.19B | 44.19% |
| 1998-03-31 | $2.56B | $1.13B | 44.17% |
| 1997-12-31 | $2.49B | $1.11B | 44.54% |
| 1997-09-30 | $2.31B | $0.98B | 42.22% |
| 1997-06-30 | $2.16B | $0.84B | 39.06% |
| 1997-03-31 | $1.99B | $0.71B | 35.82% |
| 1996-12-31 | $1.81B | $0.57B | 31.55% |
| 1996-09-30 | $1.75B | $0.64B | 36.77% |
| 1996-06-30 | $1.68B | $0.61B | 36.25% |
| 1996-03-31 | $1.60B | $0.55B | 34.13% |
| 1995-12-31 | $1.52B | $0.48B | 31.71% |
| 1995-09-30 | $1.45B | $0.35B | 24.10% |
| 1995-06-30 | $1.37B | $0.33B | 23.89% |
| 1995-03-31 | $1.34B | $0.34B | 25.54% |
| 1994-12-31 | $1.29B | $0.36B | 27.56% |
| 1994-09-30 | $1.22B | $0.33B | 27.30% |
| 1994-06-30 | $1.18B | $0.31B | 26.64% |
| 1994-03-31 | $1.12B | $0.29B | 26.34% |
| 1993-12-31 | $1.08B | $0.28B | 26.23% |
| 1993-09-30 | $1.05B | $0.28B | 26.69% |
| 1993-06-30 | $1.01B | $0.27B | 26.63% |
| 1993-03-31 | $0.99B | $0.26B | 26.21% |
| 1992-12-31 | $0.96B | $0.25B | 25.94% |
| 1992-09-30 | $0.91B | $0.22B | 23.88% |
| 1992-06-30 | $0.88B | $0.20B | 23.20% |
| 1992-03-31 | $0.84B | $0.20B | 23.21% |
| 1991-12-31 | $0.83B | $0.20B | 23.56% |
| 1991-09-30 | $0.85B | $0.22B | 25.53% |
| 1991-06-30 | $0.87B | $0.23B | 26.96% |
| 1991-03-31 | $0.87B | $0.24B | 28.08% |
| 1990-12-31 | $0.85B | $0.25B | 29.08% |
| 1990-09-30 | $0.79B | $0.24B | 29.63% |
| 1990-06-30 | $0.75B | $0.23B | 30.25% |
| 1990-03-31 | $0.74B | $0.23B | 30.82% |
| 1989-12-31 | $0.76B | $0.24B | 31.31% |
| 1989-09-30 | $0.73B | $0.24B | 32.83% |
| 1989-06-30 | $0.72B | $0.24B | 32.83% |
| 1989-03-31 | $0.72B | $0.24B | 32.78% |
| 1988-12-31 | $0.71B | $0.23B | 32.77% |
| 1988-09-30 | $0.59B | $0.21B | 36.03% |
| 1988-06-30 | $0.62B | $0.21B | 34.30% |
| 1988-03-31 | $0.62B | $0.21B | 32.85% |
| 1987-12-31 | $0.62B | $0.20B | 31.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $142.882B | $24.568B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |